Immunohistochemical evaluation of leptin expression in wound healing: A clue to exuberant scar formation

Applied Immunohistochemistry and Molecular Morphology

Volumn 24, Issue 4, 2016, Pages 296-306

  Seleit, Iman ^a   Bakry, Ola A ^a   Samaka, Rehab M ^a   Tawfik, Amira S ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Hypertrophic Scar; Keloid; Leptin; Pathogenesis; Wound

Indexed keywords

LEPTIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; COLLAGEN DEGRADATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; FAMILY HISTORY; FEMALE; FIBROBLAST; HUMAN; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; KELOID; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SCAR FORMATION; SKIN BIOPSY; WOUND HEALING; CASE CONTROL STUDY; METABOLISM; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CICATRIX, HYPERTROPHIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KELOID; LEPTIN; MALE; PROSPECTIVE STUDIES; WOUND HEALING; YOUNG ADULT;

EID: 84963632109     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0000000000000187     Document Type: Article

References (63)

1. Nguyen DT, Orgill DP, Murphy GF. The pathophysiologic basis for wound healing and cutaneous regeneration. In: Orgill DP, Blanco C, eds. Biomaterials for Treating Skin Loss. Cambridge: Woodhead Publishing Limited; 2009:25-57.
2. Rodero MP, Khosrotehrani K. Skin wound healing modulation by macrophages. Int J Clin Exp Pathol. 2010;3:643-653.
3. Hong WX, Hu MS, Esquivel M, et al. The role of hypoxia-inducible factor in wound healing. Adv Wound Care. 2014;3:390-399.
4. Akaishi S, Ogawa R, Hyakusoku H. Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses. 2008;71:32-38.
5. Louw L. The keloid phenomenon: progress toward a solution. Clin Anat. 2007;20:3-14.
6. Shih B, Garside E, McGrouther DA, et al. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen. 2010;18:139-153.
7. Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr. 2006;18:396-402.
8. Moulin V, Larochelle S, Langlois C, et al. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol. 2004;198:350-358.
9. Price T, Farr S, Yi X, et al. Transport across the blood brain barrier of pleuronic leptin. J Pharmacol Exp Ther. 2010;333:253-263.
10. Gorska E, Popko K, Stelmaszczyk-Emmel A, et al. Leptin receptors. Eur J Med Res. 2010;2:50-54.
11. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OBR. Cell. 1995;83:1263-1271.
12. Stallmeyer B, Kampfer H, Podda M, et al. A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair. J Invest Dermatol. 2001;117:98-105.
13. Cao Y, Gao F, Li CZ, et al. Expression of leptin and its long-form receptor in the marginal cutaneous tissues of diabetic foot ulcers. Acta Diabetol. 2012;49:S205-S214.
14. Beausang E, Floyd H, Dunn KW, et al. A new quantitative scale for clinical scar assessment. Plast Reconstr Surg. 1998;102:1954-1961.
15. Tsai MC, Chen W, Cheng Y, et al. Higher body mass index is a significant risk factor for acne formation in schoolchildren. Eur J Dermatol. 2006;163:251-253.
16. Grundy S, Cleeman J, Daniels S, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart Lung and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
17. Mendez-Lopez LF, Davila-Rodriguez MI, Zavala-Pompa A, et al. Expression of leptin receptor in endometrial biopsies of endometrial and ovarian cancer patients. Biomed Rep. 2013;1:659-663.
18. Smyth J, Gourley C, Walker G. Anti estrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor positive patients. Clin Cancer Res. 2007;13:3617-3622.
19. Lin J, Yan G. Roles of leptin-mediated intracellular signaling pathways on wound healing. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007;21:1254-1258.
20. Frank S, Stallmeyer B, Kampfer H, et al. Leptin enhances wound reepithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest. 2000;106:501-509.
21. Liapakis IE, Anagnostoulis S, Karayiannakis AJ, et al. Exoge-nously-administered leptin increases early incisional wound angio-genesis in an experimental animal model. In Vivo. 2007;21:797-801.
22. Sano S, Itami S, Takeda K, et al. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 1999;18:4657-4668.
23. Sano S, Takeda J, Yoshikawa K, et al. Tissue regeneration: hair follicle as a model. J Investig Dermatol Symp Proc. 2001;6:43-48.
24. Ring BD, Scully S, Davis CR, et al. Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice. Endocrinology. 2000;141:446-449.
25. Chen HC, Smith SJ, Tow B, et al. Leptin modulates the effects of acyl CoA: diacaylglycerol acyltransferase deficiency on murine fur and sebaceous glands. J Clin Invest. 2002;109:175-181.
26. Kanda N, Watanabe S. Leptin enhances b-defensin-2 production in human keratinocytes. Endocrinology. 2008;149:5189-5198.
27. Tong KM, Shieh DC, Chen CP, et al. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-jB/p300 binding in human synovial fibroblasts. Cell Signal. 2008;20:1478-1488.
28. Kawai K, Kageyama A, Tsumano T, et al. Effects of adiponectin on growth and differentiation of human keratinocytes-implication of impaired wound healing in diabetes. Biochem Biophys Res Commun. 2008;374:269-273.
29. Murad A, Nath AK, Cha ST, et al. Leptin is an autocrine/paracrine regulator of wound healing. FASEB J. 2003;17:1895-1897.
30. Behnes M, Brueckmann M, Lang S, et al. Alterations of leptin in the course of inflammation and severe sepsis. BMC Infect Dis. 2012;12:217-226.
31. Matarese G, Moschos S, Mantzoros C. Leptin in immunology. J Immunol. 2005;174:3137-3142.
32. Baumeister S, Dragu A, Jester A, et al. The role of plastic and reconstructive surgery within an inter disciplinary treatment concept for diabetic ulcers of the foot. Dtsch Med Wochenschr. 2004;129: 676-686.
33. Goren I, Kampfer H, Podda M, et al. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophils and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes. 2003;52: 2821-2832.
34. Park JS, Cho MH, Nam JS, et al. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. Acta Diabetol. 2010;47:113-118.
35. Fujiwara Y, Higuchi K, Tominaga K, et al. Quality of ulcer healing and rebamipide. Nihon Rinsho. 2005;63:397-400.
36. Marikovsky M, Rosenblum C, Faltin Z, et al. Appearance of leptin in wound fluid as a response to injury. Wound Repair Regen. 2002;10:302-307.
37. Bernotiene E, Palmer G, Gabay C. The role of leptin in innate and adaptive immune responses. Arthritis Res Ther. 2006;8:217-220.
38. Frankenberry KA, Somasundar P, McFadden DW, et al. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg. 2004;188:560-565.
39. White LA, Mitchell TI, Brinckerhoff CE. Transforming growth factor beta inhibitory element in the rabbit matrix metalloprotei-nase-1 (collagenase-1) gene functions as a repressor of constitutive transcription. Biochim Biophys Acta. 2000;1490:259-268.
40. Kumar V, Abbas AK, Fausto N, et al. Robbins Basic Pathology. 8th ed. Philadelphia: Saunders ISBN 1-4160; 2007:2973-2977.
41. Zhang ZF, Zhang YG, Hu DH, et al. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars. Burns. 2011;7: 665-672.
42. Tredget EB, Demare J, Chandran G, et al. Transforming growth factor-beta and its effect on reepithelialization of partial-thickness ear wounds in transgenic mice. Wound Repair Regen. 2005;13:61-67.
43. Messadi DV, Le A, Berg S, et al. Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts. Front Biosci. 1998; 3:16-22.
44. Guler HP, Zapf J, Scheiwiller E, et al. Recombinant human insulinlike growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA. 1988;85:4889-4893.
45. Dasu MR, Barrow RE, Spies M, et al. Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts. Burn. 2003;29:527-531.
46. Zhang J, Lin Z, Jiang H, et al. The dynamic expression of TNF-alpha mRNA of hypertrophic scars and its role. Zhonghua Zheng Xing Wai Ke Za Zhi. 2004;20:57-59.
47. Mihara M, Moriyama Y, Kishimoto T, et al. IL6 induces the proliferation of synovial fibroblastic cells in the presence of soluble IL6 receptor. Br J Rheumatol. 1995;34:321-325.
48. Xue H, Mc Cauley RL, Zhang W. Elevated IL6 expression in keloid fibroblasts. J Surg Res. 2000;89:74-77.
49. Khoo YT, Ong CT, Mukhopadhyay A, et al. Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast co culture contributes to keloid pathogenesis. J Cell Physiol. 2006;208:336-343.
50. Ong CT, Khoo YT, Tan EK, et al. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion. J Pathol. 2007;211:95-108.
51. Kizu Y, Sakurai H, Katauiri S, et al. Immunohistological analysis of transforming growth factor-b1 expression in normal and inflammed salivary glands. J Clin Pathol. 1996;49:728-732.
52. Schulz LC, Widmaier EP. The effect of leptin on mouse trophoblast cell invasion. Biol Reprod. 2004;71:1963-1967.
53. Brown JJ, Bayat A. A genetic susceptibility to raised dermal scarring. Br J Dermatol. 2009;161:8-18.
54. Lim IJ, Phan TT, Song C, et al. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg. 2001;107:797-808.
55. Lim IJ, Phan TT, Bay BH, et al. Fibroblasts co-cultured with keloid keratinocytes: normal fibroblasts secrete collagen in keloid like manner. Am J Physiol Cell Physiol. 2002;283:212-222.
56. McConway M, Johnson D, Kelly A, et al. Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans. Ann Clin Biochem. 2000;37: 717-723.
57. Sowers MR, Wildman RP, Mancuso P, et al. Change in adipocytokines and ghrelin with menopause. Maturitas. 2008;59: 149-157.
58. Ajal OM, Ogunro P, Elusanmi GF, et al. Chages in serum leptin during phase of menstrual cycle of fertile women: relationship to age groups and fertility. Int J Endocrinol Metab. 2013;11:27-33.
59. Lassek WD, Gaulin SJ. Menarche is related to fat distribution. Am J Phys Anthropol. 2007;133:1147-1151.
60. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodys-trophy. J Clin Invest. 2002;109:1345-1350.
61. Bertin E, Rich N, Schneider N, et al. Insulin and body fat distribution have no direct effect on plasma leptin levels in obese Caucasian women with and without type 2 diabetes mellitus. Diabetes Metab. 1998;24:229-234.
62. Lamberts SW, Van den Beld AW, Van der Lely AJ. The endocrinology of aging. Science. 1997;278:419-424.
63. Ruhl CE, Harris TB, Ding J, et al. Body mass index and serum leptin concentration independently estimate percentage body fat in older adults. Am J Clin Nutr. 2007;85:1121-1126.